AI Portfolio Summary
In 2025 Q4, Versant Venture Management, LLC maintained a portfolio of 9 distinct positions. Conversely, Versant Venture Management, LLC completely exited their position in Repare Therapeutics,.
Total Positions
9
Quarter
2025 Q4
Top Holding
GLUE (45.5%)
Top 10 Concentration
100.0%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
1-9 of 9
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
GLUE
Monte Rosa Ther...
|
Healthcare | 45.49% | 19.72% |
#1
1
Prev: #2
|
10.0 | -1,270,235 | -22.5% |
P
S
|
4,382,687 | $68,720,532 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
LENZ
Lenz Therapeuti...
|
Healthcare | 28.14% | 58.25% |
#2
1
Prev: #1
|
10.0 | no change | no change |
P
S
|
2,656,888 | $42,510,208 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
JBIO
Jade Bioscience...
|
Healthcare | 15.59% | 6.20% |
#3
Prev: #3
|
6.2 | no change | no change |
P
S
|
1,525,820 | $23,543,403 | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CRSP
CRISPR Therapeu...
|
Healthcare | 5.17% | 4.54% |
#4
Prev: #4
|
2.1 | no change | no change |
P
S
|
148,831 | $7,804,698 | 2018 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CTNM
Contineum Thera...
|
Healthcare | 4.11% | 3.00% |
#5
1
Prev: #6
|
1.6 | no change | no change |
P
S
|
542,628 | $6,202,238 | 2024 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SKYE
Skye Bioscience...
|
Healthcare | 1.00% | 3.71% |
#6
1
Prev: #5
|
0.4 | no change | no change |
P
S
|
2,007,704 | $1,505,176 | 2024 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
N/A
Tempest Therape...
|
—
|
Unknown | 0.51% | 1.31% |
#7
1
Prev: #8
|
0.2 | no change | no change |
P
S
|
269,772 | $774,246 | — | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | ||
|
RPTX
Repare Therapeu...
|
Healthcare | 0.00% | 2.19% |
Sold All 😨
(Was: #7) |
0.3 | -2,646,657 | -100.0% |
CLOSED
|
— | $— | 2023 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ADVM
Adverum Biotech...
|
Healthcare | 0.00% | 1.08% |
Sold All 😨
(Was: #9) |
0.3 | -506,821 | -100.0% |
CLOSED
|
— | $— | 2020 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) |
Showing 1-9 of 9 holdings